Glomerular eicosanoid production in acute serum sickness nephritis

Area of Science:

• Nephrology
• Immunology
• Prostaglandin Biology

Background:

• Immune-mediated glomerular injury, such as serum sickness nephritis, can alter renal eicosanoid production.
• Cyclooxygenase (COX) products, including thromboxane B2 (TXB2), 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha), and prostaglandin E2 (PGE2), play roles in renal function and inflammation.

Purpose of the Study:

• To investigate the impact of immune-mediated glomerular injury on the production of specific glomerular cyclooxygenase products.
• To assess the effect of inhibiting thromboxane synthetase on these products and proteinuria in a rabbit model of nephritis.

Main Methods:

• Acute serum sickness nephritis was induced in rabbits using bovine serum albumin (BSA).
• Animals were grouped into BSA-induced nephritis, control (saline), and BSA with thromboxane synthetase inhibitor (OKY-046) treatment.
• Glomeruli were isolated to measure TXB2, 6-keto-PGF1 alpha, and PGE2 production.

Main Results:

• BSA-induced nephritis resulted in severe proteinuria and glomerular lesions.
• Glomeruli from nephritic rabbits showed reduced production of PGE2 and 6-keto-PGF1 alpha, with a smaller reduction in TXB2.
• Treatment with OKY-046 significantly decreased TXB2 production but did not alter proteinuria levels.

Conclusions:

• Immune-mediated glomerular injury significantly alters glomerular cyclooxygenase product formation, notably reducing PGE2 and 6-keto-PGF1 alpha.
• While thromboxane synthetase inhibition reduces TXB2, it does not ameliorate proteinuria in this model of acute serum sickness nephritis.